Biolife solutions announces closing of stirling ultracold acquisition and expanded partnership with leading global biopharma cdmo

Bothell, wash., may 3, 2021 /prnewswire/ -- biolife solutions , inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed the previously announced acquisition of stirling ultracold ("stirling"), a privately held manufacturer of ultra-low temperature ("ult") mechanical freezers.
BLFS Ratings Summary
BLFS Quant Ranking